Dr. Juliane Fischer joins Dynamic42 as Marketing Manager
We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.
We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.
Following their Master's studies, Daria and Sophie join our lab team as research assistants.
The RUBIN Alliance "ATHANA" (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.
Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round.
BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.
A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.
Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companies
We were featured as a member of medways e.V. in Wirtschaftsspiegel.
In an interview with the trade journal "Laborjournal", our managing directors explain how the Dynamic42 biotech chips work and how the "mini-organs" used contribute to reducing animal experiments.
An article in the MED Engineering journal explained the potential of our "mini organs" from the laboratory for drug and food testing.